FHH-Chr 1BN/Mcwi |
absolute change in body temperature |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) then running on treadmill (1.6 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
8 |
|
-0.07 |
degrees C |
0.38 |
1.08 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16007 |
381 |
FHH-Chr 1BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
15 |
|
158.35 |
breaths/min |
5.58 |
21.6 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17126 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
16 |
|
108.51 |
% |
3.5 |
14.0 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53912 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
16 |
|
106.0 |
% |
4.38 |
17.51 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54013 |
381 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82 days-99 days |
8 |
|
118.6 |
mmHg |
6.44 |
18.21 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20052 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in partial pressure of blood carbon dioxide |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82 days-99 days |
8 |
|
-6.02 |
mmHg |
1.38 |
3.91 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20086 |
381 |
FHH-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
18 |
|
105.19 |
breaths/min |
4.26 |
18.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18425 |
381 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82 days-99 days |
7 |
|
114.15 |
mmHg |
3.97 |
10.52 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18916 |
381 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82 days-99 days |
9 |
|
30.64 |
mmHg |
1.37 |
4.12 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14483 |
381 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
|
86.28 |
ml/min |
3.79 |
14.66 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14515 |
381 |
FHH-Chr 1BN/Mcwi |
blood pH |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82 days-99 days |
8 |
|
7.45 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
14602 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
15 |
|
-0.69 |
degrees C |
0.36 |
1.4 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15684 |
381 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82 days-99 days |
8 |
|
113.99 |
mmHg |
3.85 |
10.9 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15141 |
381 |
FHH-Chr 1BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
9 |
|
445.83 |
beats/min |
7.54 |
22.62 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52513 |
482 |
FHH-Chr 1BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
10 |
|
0.94 |
mEq/d |
0.09 |
0.27 |
flame atomic emission spectrometry |
|
0 |
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52338 |
482 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82 days-99 days |
11 |
|
25.93 |
mmHg |
1.05 |
3.47 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13446 |
381 |
FHH-Chr 1BN/Mcwi |
heart rate |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82 days-99 days |
8 |
|
403.98 |
beats/min |
13.88 |
39.25 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17744 |
381 |
FHH-Chr 1BN/Mcwi |
heart rate |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82 days-99 days |
12 |
|
439.05 |
beats/min |
5.79 |
20.07 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17758 |
381 |
FHH-Chr 1BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82 days-99 days |
22 |
|
224.4 |
g |
5.5 |
25.9 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Dyets |
17832 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
18 |
|
-0.34 |
degrees C |
0.19 |
0.82 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20324 |
381 |
FHH-Chr 1BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
94.47 |
mmHg |
5.26 |
15.79 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49903 |
461 |
FHH-Chr 1BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49 days-63 days |
10 |
|
9.2 |
% |
4.39 |
13.88 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49724 |
461 |
FHH-Chr 1BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77 days-91 days |
12 |
|
1.12 |
x 1000 cells/ul |
0.15 |
0.5 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38948 |
401 |
FHH-Chr 1BN/Mcwi |
mean corpuscular volume |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77 days-91 days |
13 |
|
58.02 |
fl |
0.58 |
2.09 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38760 |
401 |
FHH-Chr 1BN/Mcwi |
serum albumin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77 days-91 days |
15 |
|
3.89 |
g/dl |
0.05 |
0.19 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42248 |
401 |
FHH-Chr 1BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
14 |
|
8.26 |
x 10E6 cells/ul |
0.09 |
0.32 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42046 |
401 |
FHH-Chr 1BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
16 |
|
127.3 |
% |
7.08 |
28.32 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54353 |
381 |
FHH-Chr 1BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77 days-91 days |
18 |
|
4.44 |
mmol/l |
0.09 |
0.4 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43379 |
401 |
FHH-Chr 1BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77 days-91 days |
9 |
|
2.96 |
mg/kg |
1.01 |
3.03 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58932 |
526 |
FHH-Chr 1BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
15 |
|
163.65 |
% |
8.9 |
34.46 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53652 |
381 |
FHH-Chr 1BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77 days-91 days |
18 |
|
3.88 |
g/dl |
0.04 |
0.17 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40484 |
401 |
FHH-Chr 1BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77 days-91 days |
18 |
|
0.9 |
g/kg |
0.03 |
0.11 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59506 |
526 |
FHH-Chr 1BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77 days-91 days |
18 |
|
84.83 |
U/l |
6.37 |
27.02 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37759 |
401 |
FHH-Chr 1BN/Mcwi |
plasma anion gap |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77 days-91 days |
9 |
|
23.67 |
mmol/l |
0.71 |
2.12 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38287 |
401 |
FHH-Chr 1BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77 days-91 days |
18 |
|
73.83 |
mg/dl |
1.31 |
5.55 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38510 |
401 |
FHH-Chr 1BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77 days-91 days |
18 |
|
15.33 |
mg/dl |
0.68 |
2.89 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41804 |
401 |
FHH-Chr 1BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
125.16 |
mmHg |
4.18 |
12.54 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45519 |
461 |
FHH-Chr 1BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
9 |
|
1143.03 |
s |
39.64 |
118.91 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46574 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
10 |
|
143.14 |
mmHg |
6.57 |
20.76 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48639 |
461 |
FHH-Chr 1BN/Mcwi |
serum total bilirubin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77 days-91 days |
15 |
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41883 |
401 |
FHH-Chr 1BN/Mcwi |
serum total bilirubin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77 days-91 days |
9 |
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41894 |
401 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
-7.56 |
null |
0.07 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55318 |
522 |
FHH-Chr 1BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
13 |
|
15.64 |
ml/min/kg |
1.23 |
4.43 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57613 |
526 |
FHH-Chr 1BN/Mcwi |
absolute change in partial pressure of blood oxygen |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82 days-99 days |
8 |
|
11.24 |
mmHg |
3.48 |
9.84 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16289 |
381 |
FHH-Chr 1BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
26 |
|
1.43 |
g/mg |
0.07 |
0.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57376 |
522 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood oxygen |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82 days-99 days |
9 |
|
106.11 |
mmHg |
3.28 |
9.83 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16417 |
381 |
FHH-Chr 1BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
215.6 |
g |
5.0 |
15.8 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55457 |
522 |
FHH-Chr 1BN/Mcwi |
FAPGG metabolism-surface area product |
air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
12 |
|
52.21 |
ml/min/kg |
5.22 |
18.09 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58014 |
526 |
FHH-Chr 1BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
18 |
|
37.81 |
degrees C |
0.16 |
0.68 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16827 |
381 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
26 |
|
-7.27 |
null |
0.14 |
0.73 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56171 |
522 |
FHH-Chr 1BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
26 |
|
0.17 |
umol/l |
0.04 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54972 |
522 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
13.07 |
% |
3.87 |
14.47 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55097 |
522 |
FHH-Chr 1BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
0.13 |
mmHg x min x kg x ml-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59965 |
526 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
50.67 |
% |
3.64 |
10.92 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57182 |
522 |
FHH-Chr 1BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
10 |
|
5.18 |
mmHg |
0.28 |
0.89 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47212 |
461 |
FHH-Chr 1BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
10 |
|
260.6 |
beats/min |
21.86 |
69.14 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45163 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
97.25 |
% |
4.99 |
14.12 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44944 |
461 |
FHH-Chr 1BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
0.33 |
IU/g |
0.1 |
0.3 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47373 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
81.32 |
% |
3.3 |
9.9 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48432 |
461 |
FHH-Chr 1BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
10 |
|
0.78 |
g |
0.04 |
0.12 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49075 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
14 |
|
181.14 |
% |
5.27 |
19.73 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54112 |
381 |
FHH-Chr 1BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82 days-99 days |
8 |
|
476.99 |
beats/min |
8.09 |
22.88 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20970 |
381 |
FHH-Chr 1BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
14 |
|
0.28 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15423 |
381 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82 days-99 days |
8 |
|
120.39 |
mmHg |
5.08 |
14.36 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13512 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
276.47 |
% |
13.87 |
53.73 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14213 |
381 |
FHH-Chr 1BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
15 |
|
171.41 |
breaths/min |
6.56 |
25.41 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16926 |
381 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82 days-99 days |
8 |
|
135.91 |
mmHg |
6.19 |
17.52 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18945 |
381 |
FHH-Chr 1BN/Mcwi |
heart rate |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82 days-99 days |
8 |
|
495.06 |
beats/min |
14.24 |
40.28 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13801 |
381 |
FHH-Chr 1BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
16 |
|
113.79 |
breaths/min |
5.38 |
21.54 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14820 |
381 |
FHH-Chr 1BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
14 |
|
37.21 |
degrees C |
0.24 |
0.89 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19095 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
14 |
%change=VE during 2-3 min hypercapnia/control during standard conditions |
272.29 |
% |
10.49 |
39.25 |
stop flow air displacement plethysmography |
0 |
0 |
|
|
Moms and pups used in studies were fed Teklad |
19237 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
93.4 |
% |
3.73 |
11.8 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48321 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
15.29 |
ml/min/g |
0.72 |
2.27 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46679 |
461 |
FHH-Chr 1BN/Mcwi |
heart weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
10 |
|
6.12 |
g/kg |
0.25 |
0.78 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45684 |
461 |
FHH-Chr 1BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49 days-63 days |
10 |
|
173.6 |
g |
10.5 |
33.1 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47856 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
71.44 |
% |
10.82 |
32.47 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44933 |
461 |
FHH-Chr 1BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
14 |
|
0.51 |
ml |
0.03 |
0.09 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16499 |
381 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
-6.9 |
null |
0.07 |
0.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55668 |
522 |
FHH-Chr 1BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77 days-91 days |
14 |
|
5.3 |
x 1000 cells/ul |
0.51 |
1.89 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39962 |
401 |
FHH-Chr 1BN/Mcwi |
mean corpuscular hemoglobin concentration |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
9 |
|
32.01 |
g/dl |
0.12 |
0.37 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39803 |
401 |
FHH-Chr 1BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
0.03 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54742 |
522 |
FHH-Chr 1BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
9 |
|
0.34 |
IU/g |
0.06 |
0.19 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47486 |
461 |
FHH-Chr 1BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
body mass |
female |
77 days-91 days |
10 |
|
163.7 |
g |
3.9 |
12.3 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59088 |
526 |
FHH-Chr 1BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
24 |
|
0.19 |
umol/l |
0.05 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54948 |
522 |
FHH-Chr 1BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77 days-91 days |
16 |
|
0.31 |
null |
0.02 |
0.08 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58748 |
526 |
FHH-Chr 1BN/Mcwi |
serum alanine aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77 days-91 days |
15 |
|
89.13 |
U/l |
10.4 |
40.29 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40729 |
401 |
FHH-Chr 1BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
28 |
|
1.96 |
g/mg |
0.16 |
0.86 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57400 |
522 |
FHH-Chr 1BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77 days-91 days |
18 |
|
380.28 |
U/l |
22.96 |
97.4 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37502 |
401 |
FHH-Chr 1BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77 days-91 days |
18 |
|
255.28 |
U/l |
13.46 |
57.11 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37527 |
401 |
FHH-Chr 1BN/Mcwi |
serum phosphate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77 days-91 days |
15 |
|
8.84 |
mg/dl |
0.38 |
1.49 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37609 |
401 |
FHH-Chr 1BN/Mcwi |
serum phosphate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77 days-91 days |
9 |
|
8.26 |
mg/dl |
0.26 |
0.79 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37620 |
401 |
FHH-Chr 1BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
9 |
|
55.3 |
% |
0.61 |
1.84 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39017 |
401 |
FHH-Chr 1BN/Mcwi |
mean corpuscular hemoglobin |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
13 |
|
18.86 |
pg |
0.32 |
1.14 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42560 |
401 |
FHH-Chr 1BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
0.15 |
mmHg x min x kg x ml-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59573 |
526 |
FHH-Chr 1BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
13 |
|
0.14 |
mmHg x min x kg x ml-1 |
0.01 |
0.04 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59562 |
526 |
FHH-Chr 1BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
173.7 |
g |
5.5 |
17.4 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55482 |
522 |
FHH-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
14 |
|
116.89 |
breaths/min |
7.15 |
26.74 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14961 |
381 |
FHH-Chr 1BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
10 |
|
11.87 |
mEq/d |
2.05 |
6.48 |
flame atomic emission spectrometry |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52826 |
482 |
FHH-Chr 1BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
7 |
|
3.1 |
ng/ml/h |
0.58 |
1.53 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52907 |
482 |
FHH-Chr 1BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
10 |
|
1.27 |
mEq/d |
0.08 |
0.25 |
flame atomic emission spectrometry |
|
0 |
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52321 |
482 |
FHH-Chr 1BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
10 |
|
9.79 |
mg/d |
2.7 |
8.53 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52432 |
482 |
FHH-Chr 1BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
18 |
|
0.37 |
ml |
0.02 |
0.08 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13938 |
381 |
FHH-Chr 1BN/Mcwi |
heart rate |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82 days-99 days |
12 |
|
499.19 |
beats/min |
11.73 |
40.63 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13815 |
381 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood gas amount |
male |
82 days-99 days |
11 |
|
27.65 |
mmHg |
0.67 |
2.22 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17268 |
381 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82 days-99 days |
7 |
|
116.98 |
mmHg |
6.2 |
16.39 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14379 |
381 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
14 |
|
87.04 |
ml/min |
4.07 |
15.21 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14526 |
381 |
FHH-Chr 1BN/Mcwi |
blood pH |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82 days-99 days |
11 |
|
7.46 |
null |
0.01 |
0.04 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
14616 |
381 |
FHH-Chr 1BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
16 |
|
0.32 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15259 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
15 |
|
151.06 |
% |
6.84 |
26.49 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54237 |
381 |
FHH-Chr 1BN/Mcwi |
body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
15 |
|
36.61 |
degrees C |
0.29 |
1.11 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13574 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in heart rate |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82 days-99 days |
12 |
heart rate during walking-heart rate during rest |
60.15 |
beats/min |
13.17 |
45.61 |
vascular fluid filled catheter |
0 |
0 |
|
|
Moms and pups used in studies were fed Teklad |
13412 |
381 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82 days-99 days |
8 |
|
26.46 |
mmHg |
1.05 |
2.97 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13432 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
18 |
|
122.48 |
% |
6.61 |
28.03 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53771 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
18 |
|
115.65 |
% |
4.49 |
19.07 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53903 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in blood pH |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82 days-99 days |
7 |
|
0.04 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19831 |
381 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82 days-99 days |
8 |
|
116.27 |
mmHg |
6.93 |
19.61 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19893 |
381 |
FHH-Chr 1BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
18 |
|
0.32 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17997 |
381 |
FHH-Chr 1BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
16 |
|
0.31 |
ml |
0.01 |
0.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18008 |
381 |
FHH-Chr 1BN/Mcwi |
body temperature |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) then running on treadmill (1.6 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
12 |
|
37.23 |
degrees C |
0.33 |
1.15 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17660 |
381 |
FHH-Chr 1BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82 days-99 days |
7 |
|
7.44 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20670 |
381 |
FHH-Chr 1BN/Mcwi |
serum alkaline phosphatase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77 days-91 days |
15 |
|
390.33 |
U/l |
17.97 |
69.6 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36394 |
401 |
FHH-Chr 1BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
14 |
|
31.95 |
g/dl |
0.1 |
0.39 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37405 |
401 |
FHH-Chr 1BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77 days-91 days |
18 |
|
5.67 |
g/dl |
0.05 |
0.23 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37250 |
401 |
FHH-Chr 1BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82 days-99 days |
7 |
|
467.14 |
beats/min |
24.71 |
65.38 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17552 |
381 |
FHH-Chr 1BN/Mcwi |
body temperature |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
12 |
|
37.58 |
degrees C |
0.13 |
0.46 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18144 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in partial pressure of blood oxygen |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82 days-99 days |
9 |
|
-52.62 |
mmHg |
2.5 |
7.49 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19491 |
381 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood oxygen |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82 days-99 days |
11 |
|
55.07 |
mmHg |
1.17 |
3.89 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20503 |
381 |
FHH-Chr 1BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49 days-63 days |
10 |
|
4.73 |
% |
2.0 |
6.34 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49411 |
461 |
FHH-Chr 1BN/Mcwi |
serum chloride level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77 days-91 days |
9 |
|
111.56 |
mmol/l |
0.71 |
2.13 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39143 |
401 |
FHH-Chr 1BN/Mcwi |
serum bicarbonate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77 days-91 days |
15 |
|
14.93 |
mmol/l |
0.48 |
1.87 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42077 |
401 |
FHH-Chr 1BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77 days-91 days |
18 |
|
22.17 |
mmol/l |
0.47 |
1.98 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43067 |
401 |
FHH-Chr 1BN/Mcwi |
blood monocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77 days-91 days |
9 |
|
0.26 |
x 1000 cells/ul |
0.06 |
0.18 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39700 |
401 |
FHH-Chr 1BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77 days-91 days |
18 |
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42935 |
401 |
FHH-Chr 1BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
body mass |
male |
77 days-91 days |
16 |
|
178.9 |
g |
3.3 |
13.1 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59077 |
526 |
FHH-Chr 1BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
14 |
|
151.9 |
% |
7.66 |
28.64 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53661 |
381 |
FHH-Chr 1BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77 days-91 days |
17 |
|
2.89 |
mg/kg |
0.49 |
2.02 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59216 |
526 |
FHH-Chr 1BN/Mcwi |
blood hemoglobin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
13 |
|
18.48 |
g/dl |
0.33 |
1.2 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37983 |
401 |
FHH-Chr 1BN/Mcwi |
blood hemoglobin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
9 |
|
17.71 |
g/dl |
0.23 |
0.7 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37994 |
401 |
FHH-Chr 1BN/Mcwi |
lung dry weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77 days-91 days |
16 |
|
1.52 |
g/kg |
0.07 |
0.26 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59672 |
526 |
FHH-Chr 1BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77 days-91 days |
18 |
|
141.39 |
mg/dl |
3.76 |
15.95 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41246 |
401 |
FHH-Chr 1BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
10 |
|
0.39 |
IU/g |
0.08 |
0.27 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47511 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
54.65 |
mmHg |
3.65 |
10.95 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46432 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
68.29 |
% |
3.41 |
10.79 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48782 |
461 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82 days-99 days |
7 |
|
33.44 |
mmHg |
0.81 |
2.14 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16116 |
381 |
FHH-Chr 1BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
13.84 |
ml/min/kg |
0.9 |
2.84 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57624 |
526 |
FHH-Chr 1BN/Mcwi |
FAPGG metabolism-surface area product |
air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
50.5 |
ml/min/kg |
3.82 |
12.09 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58025 |
526 |
FHH-Chr 1BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
1.32 |
g/mg |
0.06 |
0.19 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55856 |
522 |
FHH-Chr 1BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
1.36 |
E-7mole |
0.21 |
0.56 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55937 |
522 |
FHH-Chr 1BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
0.04 |
10E-7mol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55749 |
522 |
FHH-Chr 1BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
99.33 |
% |
0.35 |
1.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56319 |
522 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
19 |
|
-8.75 |
null |
0.14 |
0.62 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56042 |
522 |
FHH-Chr 1BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
male |
77 days-91 days |
13 |
|
0.03 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58504 |
526 |
FHH-Chr 1BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
16 |
|
15.15 |
ml/min/kg |
2.02 |
8.09 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58675 |
526 |
FHH-Chr 1BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
99.56 |
% |
0.34 |
1.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56479 |
522 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
16 |
|
48.06 |
% |
6.51 |
26.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57150 |
522 |
FHH-Chr 1BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
8 |
|
110.75 |
mmHg |
4.97 |
14.05 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
|
46776 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
99.51 |
mmHg |
6.66 |
19.97 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44830 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
59.33 |
mmHg |
8.69 |
26.07 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47926 |
461 |
FHH-Chr 1BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
0.21 |
IU/g |
0.04 |
0.11 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47350 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
45.23 |
% |
9.67 |
29.0 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46334 |
461 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
16 |
|
36.64 |
ml/min |
2.19 |
8.74 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20234 |
381 |
FHH-Chr 1BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
|
0.27 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15412 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
14 |
|
-0.07 |
degrees C |
0.21 |
0.78 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15695 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in blood pH |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82 days-99 days |
9 |
|
-0.01 |
null |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14777 |
381 |
FHH-Chr 1BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77 days-91 days |
14 |
|
4.39 |
x 1000 cells/ul |
0.55 |
2.05 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36946 |
401 |
FHH-Chr 1BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
10 |
|
189.0 |
mg/d |
36.58 |
115.68 |
automated urine total protein analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52123 |
482 |
FHH-Chr 1BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
98.7 |
% |
10.16 |
32.14 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48421 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
7.43 |
ml/min/g |
0.25 |
0.79 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44744 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
12.92 |
ml/min/g |
1.26 |
3.79 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46896 |
461 |
FHH-Chr 1BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
10 |
|
41.1 |
mmHg |
1.92 |
6.08 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48048 |
461 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
-6.94 |
null |
0.11 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55693 |
522 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
18 |
|
33.67 |
ml/min |
1.66 |
7.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16705 |
381 |
FHH-Chr 1BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
0.31 |
null |
0.02 |
0.07 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58139 |
526 |
FHH-Chr 1BN/Mcwi |
plasma creatinine level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77 days-91 days |
9 |
|
0.24 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39602 |
401 |
FHH-Chr 1BN/Mcwi |
blood lymphocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77 days-91 days |
13 |
|
3.83 |
x 1000 cells/ul |
0.41 |
1.48 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41518 |
401 |
FHH-Chr 1BN/Mcwi |
blood lymphocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77 days-91 days |
9 |
|
3.22 |
x 1000 cells/ul |
0.38 |
1.13 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41529 |
401 |
FHH-Chr 1BN/Mcwi |
mean corpuscular hemoglobin concentration |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
13 |
|
32.48 |
g/dl |
0.27 |
0.99 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39792 |
401 |
FHH-Chr 1BN/Mcwi |
blood neutrophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77 days-91 days |
13 |
|
0.99 |
x 1000 cells/ul |
0.12 |
0.45 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43239 |
401 |
FHH-Chr 1BN/Mcwi |
blood eosinophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77 days-91 days |
9 |
|
0.02 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41673 |
401 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
24 |
|
-7.21 |
null |
0.15 |
0.76 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56147 |
522 |
FHH-Chr 1BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
10 |
|
50.14 |
mmHg |
2.18 |
6.89 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46443 |
461 |
FHH-Chr 1BN/Mcwi |
heart wet weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
10 |
|
0.85 |
g |
0.04 |
0.12 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45431 |
461 |
FHH-Chr 1BN/Mcwi |
time to peak heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
10 |
|
1154.0 |
s |
24.51 |
77.5 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50253 |
461 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
14 |
|
32.47 |
ml/min |
1.7 |
6.36 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16173 |
381 |
FHH-Chr 1BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77 days-91 days |
18 |
|
1.72 |
g/dl |
0.05 |
0.19 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
41079 |
401 |
FHH-Chr 1BN/Mcwi |
red blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
13 |
|
9.8 |
x 10E6 cells/ul |
0.08 |
0.3 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39252 |
401 |
FHH-Chr 1BN/Mcwi |
serum sodium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77 days-91 days |
9 |
|
145.33 |
mmol/l |
0.44 |
1.32 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39414 |
401 |
FHH-Chr 1BN/Mcwi |
blood pH |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82 days-99 days |
11 |
|
7.5 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17076 |
381 |
FHH-Chr 1BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82 days-99 days |
15 |
|
450.47 |
beats/min |
8.58 |
33.22 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20949 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in mean arterial blood pressure |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82 days-99 days |
12 |
|
18.22 |
mmHg |
2.88 |
9.98 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20744 |
381 |
FHH-Chr 1BN/Mcwi |
serum alkaline phosphatase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77 days-91 days |
9 |
|
269.0 |
U/l |
8.94 |
26.82 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36405 |
401 |
FHH-Chr 1BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82 days-99 days |
7 |
|
482.19 |
beats/min |
14.03 |
37.11 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15974 |
381 |
FHH-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
15 |
|
107.11 |
breaths/min |
4.86 |
18.81 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14950 |
381 |
FHH-Chr 1BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
10 |
|
66.89 |
mg/d |
9.22 |
29.15 |
automated urine total protein analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52140 |
482 |
FHH-Chr 1BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
9 |
|
1.3 |
ml/min |
0.18 |
0.54 |
urine creatinine analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52385 |
482 |
FHH-Chr 1BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
10 |
|
68.56 |
mg/d |
16.62 |
52.55 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52415 |
482 |
FHH-Chr 1BN/Mcwi |
body temperature |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) then running on treadmill (1.6 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
8 |
|
37.81 |
degrees C |
0.38 |
1.06 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17646 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in partial pressure of blood carbon dioxide |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82 days-99 days |
9 |
|
-6.23 |
mmHg |
0.45 |
1.35 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19660 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in partial pressure of blood carbon dioxide |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82 days-99 days |
7 |
|
-5.77 |
mmHg |
0.62 |
1.65 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19681 |
381 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
18 |
|
47.81 |
ml/min |
2.7 |
11.46 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18677 |
381 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
16 |
|
40.16 |
ml/min |
2.01 |
8.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18688 |
381 |
FHH-Chr 1BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77 days-91 days |
18 |
|
143.94 |
mmol/l |
0.46 |
1.95 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36542 |
401 |
FHH-Chr 1BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77 days-91 days |
18 |
|
9.51 |
mg/dl |
0.11 |
0.47 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36811 |
401 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood oxygen |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82 days-99 days |
8 |
|
61.21 |
mmHg |
0.96 |
2.71 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20524 |
381 |
FHH-Chr 1BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
16 |
|
122.51 |
breaths/min |
6.35 |
25.4 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18291 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
15 |
|
-0.11 |
degrees C |
0.15 |
0.58 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20335 |
381 |
FHH-Chr 1BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
body mass |
male |
49 days-63 days |
10 |
|
154.6 |
g |
7.1 |
22.4 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49561 |
461 |
FHH-Chr 1BN/Mcwi |
serum chloride level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77 days-91 days |
15 |
|
110.27 |
mmol/l |
1.08 |
4.17 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39132 |
401 |
FHH-Chr 1BN/Mcwi |
serum albumin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77 days-91 days |
9 |
|
3.78 |
g/dl |
0.04 |
0.13 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42259 |
401 |
FHH-Chr 1BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77 days-91 days |
18 |
|
20.28 |
mmol/l |
0.46 |
1.93 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43208 |
401 |
FHH-Chr 1BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77 days-91 days |
18 |
|
4.13 |
mmol/l |
0.09 |
0.4 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43404 |
401 |
FHH-Chr 1BN/Mcwi |
serum globulin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77 days-91 days |
15 |
|
1.81 |
g/dl |
0.04 |
0.15 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
40565 |
401 |
FHH-Chr 1BN/Mcwi |
serum globulin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77 days-91 days |
9 |
|
1.68 |
g/dl |
0.06 |
0.17 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
40576 |
401 |
FHH-Chr 1BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77 days-91 days |
12 |
|
1.72 |
mg/kg |
0.49 |
1.71 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59241 |
526 |
FHH-Chr 1BN/Mcwi |
total white blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77 days-91 days |
9 |
|
4.11 |
x 1000 cells/ul |
0.44 |
1.33 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40952 |
401 |
FHH-Chr 1BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77 days-91 days |
18 |
|
137.72 |
mg/dl |
4.1 |
17.4 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41271 |
401 |
FHH-Chr 1BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77 days-91 days |
18 |
|
8.07 |
mg/dl |
0.19 |
0.79 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37904 |
401 |
FHH-Chr 1BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
14 |
|
46.29 |
% |
0.49 |
1.82 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41379 |
401 |
FHH-Chr 1BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77 days-91 days |
14 |
|
0.03 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41481 |
401 |
FHH-Chr 1BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
15.45 |
ml/min/kg |
0.91 |
2.87 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57826 |
526 |
FHH-Chr 1BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
|
0.51 |
ml |
0.02 |
0.1 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16488 |
381 |
FHH-Chr 1BN/Mcwi |
FAPGG metabolism-surface area product |
FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
17 |
|
39.16 |
ml/min/kg |
3.94 |
16.26 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58278 |
526 |
FHH-Chr 1BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77 days-91 days |
18 |
|
203.7 |
g |
5.5 |
23.5 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58390 |
526 |
FHH-Chr 1BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
0.05 |
10E-7mol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56244 |
522 |
FHH-Chr 1BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77 days-91 days |
13 |
|
2.78 |
mg/kg |
0.54 |
1.93 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58921 |
526 |
FHH-Chr 1BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
17 |
|
1.61 |
E-7mole |
0.35 |
1.44 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56586 |
522 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
23.0 |
% |
6.2 |
18.61 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55068 |
522 |
FHH-Chr 1BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
17 |
|
0.13 |
mmHg x min x kg x ml-1 |
0.01 |
0.03 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59940 |
526 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
11 |
|
-7.01 |
null |
0.1 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56957 |
522 |
FHH-Chr 1BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
16 |
|
9.89 |
ml/min/kg |
1.22 |
4.88 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
60046 |
526 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
17 |
|
-6.9 |
null |
0.07 |
0.29 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56981 |
522 |
FHH-Chr 1BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
6.96 |
ml/min/kg |
1.0 |
3.17 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
60071 |
526 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
44.22 |
% |
2.4 |
7.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57191 |
522 |
FHH-Chr 1BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
10 |
|
4.59 |
g/kg |
0.28 |
0.87 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47034 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
12.46 |
ml/min/g |
0.9 |
2.85 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46885 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
10 |
|
148.32 |
mmHg |
6.53 |
20.64 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45744 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
14.88 |
ml/min/g |
1.14 |
3.59 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46668 |
461 |
FHH-Chr 1BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
9 |
|
271.35 |
beats/min |
9.78 |
29.34 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48223 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
109.03 |
mmHg |
3.72 |
11.16 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44841 |
461 |
FHH-Chr 1BN/Mcwi |
ratio of change in renal blood flow to change in renal perfusion pressure |
controlled in situ renal perfusion pressure (100-140 mmHg) |
Lopez B, et al., Am J Physiol Renal Physiol. 2006 May;290(5):F1213-21. Epub 2005 Nov 22. |
renal blood flow trait |
male |
140 days
| 12 |
|
0.19 |
null |
0.05 |
0.17 |
ultrasonic flowmeter |
0.0 |
0 |
|
|
|
69371 |
1156 |
FHH-Chr 1BN/Mcwi |
blood pH |
resting on treadmill (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82 days-99 days |
9 |
|
7.46 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Dyets |
20172 |
381 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
18 |
|
42.73 |
ml/min |
1.9 |
8.07 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20223 |
381 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
|
78.45 |
ml/min |
3.87 |
14.99 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20776 |
381 |
FHH-Chr 1BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
10 |
|
5.34 |
mmHg |
0.16 |
0.51 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49192 |
461 |
FHH-Chr 1BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
9 |
|
221.52 |
beats/min |
13.46 |
40.36 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48971 |
461 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood oxygen |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82 days-99 days |
8 |
|
114.81 |
mmHg |
1.72 |
4.87 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15048 |
381 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood oxygen |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82 days-99 days |
11 |
|
114.79 |
mmHg |
1.65 |
5.48 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15062 |
381 |
FHH-Chr 1BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
14 |
|
171.74 |
breaths/min |
5.86 |
21.91 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16937 |
381 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82 days-99 days |
12 |
|
129.06 |
mmHg |
3.94 |
13.66 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18959 |
381 |
FHH-Chr 1BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
15 |
|
37.31 |
degrees C |
0.19 |
0.75 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19084 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
16 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
123.09 |
% |
5.97 |
23.86 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18569 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
18 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
143.73 |
% |
7.23 |
30.66 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13695 |
381 |
FHH-Chr 1BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
10 |
|
19.31 |
mEq/d |
1.16 |
3.66 |
flame atomic emission spectrometry |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52809 |
482 |
FHH-Chr 1BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
9 |
|
4.77 |
g/kg |
0.12 |
0.35 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47059 |
461 |
FHH-Chr 1BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
10 |
|
258.51 |
beats/min |
7.81 |
24.69 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48212 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
40.17 |
mmHg |
2.58 |
7.75 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47716 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
68.47 |
mmHg |
3.87 |
11.62 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47937 |
461 |
FHH-Chr 1BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
9 |
|
42.22 |
mmHg |
2.99 |
8.96 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48059 |
461 |
FHH-Chr 1BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77 days-91 days |
18 |
|
21.83 |
mmol/l |
0.37 |
1.58 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43042 |
401 |
FHH-Chr 1BN/Mcwi |
time to onset of heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
10 |
|
900.59 |
s |
38.21 |
120.84 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49314 |
461 |
FHH-Chr 1BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
body mass |
female |
49 days-63 days |
10 |
|
139.2 |
g |
6.4 |
20.1 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49586 |
461 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
-8.5 |
null |
0.12 |
0.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56032 |
522 |
FHH-Chr 1BN/Mcwi |
blood neutrophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77 days-91 days |
9 |
|
0.61 |
x 1000 cells/ul |
0.05 |
0.16 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43250 |
401 |
FHH-Chr 1BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
18 |
|
41.5 |
% |
5.45 |
23.12 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54846 |
522 |
FHH-Chr 1BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
13 |
|
56.87 |
% |
0.59 |
2.14 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39006 |
401 |
FHH-Chr 1BN/Mcwi |
serum urea nitrogen level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77 days-91 days |
9 |
|
19.89 |
mg/dl |
1.18 |
3.55 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40854 |
401 |
FHH-Chr 1BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77 days-91 days |
18 |
|
68.94 |
U/l |
3.29 |
13.96 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37784 |
401 |
FHH-Chr 1BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77 days-91 days |
18 |
|
94.67 |
U/l |
4.54 |
19.28 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42494 |
401 |
FHH-Chr 1BN/Mcwi |
serum potassium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77 days-91 days |
9 |
|
4.7 |
mmol/l |
0.15 |
0.44 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38092 |
401 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82 days-99 days |
8 |
|
32.49 |
mmHg |
0.78 |
2.2 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14469 |
381 |
FHH-Chr 1BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
9 |
|
0.35 |
mg/dl |
0.03 |
0.08 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52289 |
482 |
FHH-Chr 1BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
7 |
|
2.39 |
ml/min |
0.19 |
0.49 |
urine creatinine analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52368 |
482 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
10 |
|
155.42 |
mmHg |
4.94 |
15.62 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52577 |
482 |
FHH-Chr 1BN/Mcwi |
heart rate |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82 days-99 days |
8 |
|
350.86 |
beats/min |
18.24 |
51.6 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14725 |
381 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82 days-99 days |
7 |
|
116.34 |
mmHg |
5.47 |
14.47 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19912 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in mean arterial blood pressure |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82 days-99 days |
8 |
|
17.31 |
mmHg |
2.31 |
6.54 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20730 |
381 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82 days-99 days |
15 |
|
126.23 |
mmHg |
3.6 |
13.94 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15120 |
381 |
FHH-Chr 1BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82 days-99 days |
8 |
|
411.96 |
beats/min |
20.16 |
57.02 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15955 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in body temperature |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) then running on treadmill (1.6 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
12 |
|
-0.36 |
degrees C |
0.3 |
1.04 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16021 |
381 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood gas amount |
female |
82 days-99 days |
8 |
|
27.34 |
mmHg |
0.66 |
1.85 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17289 |
381 |
FHH-Chr 1BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
14 |
|
154.97 |
breaths/min |
4.51 |
16.86 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17137 |
381 |
FHH-Chr 1BN/Mcwi |
body temperature |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
8 |
|
37.89 |
degrees C |
0.13 |
0.36 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18130 |
381 |
FHH-Chr 1BN/Mcwi |
serum calcium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77 days-91 days |
15 |
|
9.12 |
mg/dl |
0.11 |
0.43 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36639 |
401 |
FHH-Chr 1BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77 days-91 days |
18 |
|
5.52 |
g/dl |
0.05 |
0.23 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37275 |
401 |
FHH-Chr 1BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
10 |
|
251.12 |
beats/min |
19.54 |
61.78 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48960 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
5.29 |
mmHg |
0.19 |
0.57 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49203 |
461 |
FHH-Chr 1BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49 days-63 days |
10 |
|
10.78 |
% |
4.5 |
14.23 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49713 |
461 |
FHH-Chr 1BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
9 |
|
890.95 |
s |
27.06 |
81.19 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50134 |
461 |
FHH-Chr 1BN/Mcwi |
time to onset of heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
10 |
|
946.07 |
s |
60.82 |
192.34 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49325 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
10 |
|
103.64 |
mmHg |
6.21 |
19.65 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49914 |
461 |
FHH-Chr 1BN/Mcwi |
mean corpuscular volume |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77 days-91 days |
9 |
|
58.19 |
fl |
0.41 |
1.24 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38771 |
401 |
FHH-Chr 1BN/Mcwi |
serum bicarbonate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77 days-91 days |
9 |
|
14.89 |
mmol/l |
0.7 |
2.09 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42088 |
401 |
FHH-Chr 1BN/Mcwi |
serum aspartate aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77 days-91 days |
14 |
|
127.93 |
U/l |
10.54 |
39.44 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42785 |
401 |
FHH-Chr 1BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
18 |
|
124.99 |
% |
5.18 |
21.99 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54344 |
381 |
FHH-Chr 1BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77 days-91 days |
18 |
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42960 |
401 |
FHH-Chr 1BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
|
185.35 |
% |
9.04 |
35.0 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54443 |
381 |
FHH-Chr 1BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77 days-91 days |
18 |
|
21.39 |
mmol/l |
0.54 |
2.3 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43183 |
401 |
FHH-Chr 1BN/Mcwi |
blood monocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77 days-91 days |
13 |
|
0.28 |
x 1000 cells/ul |
0.05 |
0.16 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39689 |
401 |
FHH-Chr 1BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
12 |
|
15.1 |
g/dl |
0.2 |
0.7 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40154 |
401 |
FHH-Chr 1BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
12 |
|
17.28 |
pg |
0.09 |
0.3 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40250 |
401 |
FHH-Chr 1BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77 days-91 days |
18 |
|
3.95 |
g/dl |
0.03 |
0.12 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40459 |
401 |
FHH-Chr 1BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77 days-91 days |
18 |
|
105.28 |
mmol/l |
0.5 |
2.14 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40058 |
401 |
FHH-Chr 1BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
male |
77 days-91 days |
17 |
|
0.03 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59410 |
526 |
FHH-Chr 1BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
female |
77 days-91 days |
10 |
|
0.05 |
mmHg-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59435 |
526 |
FHH-Chr 1BN/Mcwi |
total white blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77 days-91 days |
13 |
|
5.14 |
x 1000 cells/ul |
0.51 |
1.82 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40941 |
401 |
FHH-Chr 1BN/Mcwi |
lung dry weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77 days-91 days |
10 |
|
1.79 |
g/kg |
0.05 |
0.15 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59683 |
526 |
FHH-Chr 1BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77 days-91 days |
18 |
|
7.95 |
mg/dl |
0.1 |
0.43 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37879 |
401 |
FHH-Chr 1BN/Mcwi |
serum glucose level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77 days-91 days |
15 |
|
144.6 |
mg/dl |
6.97 |
26.99 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38545 |
401 |
FHH-Chr 1BN/Mcwi |
serum glucose level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77 days-91 days |
9 |
|
129.56 |
mg/dl |
4.75 |
14.26 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38556 |
401 |
FHH-Chr 1BN/Mcwi |
percent change in left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
26.78 |
% |
6.6 |
20.88 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48542 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
35.97 |
% |
3.49 |
11.03 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48553 |
461 |
FHH-Chr 1BN/Mcwi |
heart wet weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
10 |
|
1.0 |
g |
0.05 |
0.14 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45420 |
461 |
FHH-Chr 1BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77 days-91 days |
12 |
|
53.66 |
fl |
0.21 |
0.73 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38699 |
401 |
FHH-Chr 1BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77 days-91 days |
14 |
|
56.02 |
fl |
0.17 |
0.62 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38724 |
401 |
FHH-Chr 1BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
65.38 |
% |
8.91 |
25.19 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57292 |
522 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
-7.54 |
null |
0.09 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55343 |
522 |
FHH-Chr 1BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77 days-91 days |
12 |
|
46.96 |
% |
0.65 |
2.27 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57539 |
526 |
FHH-Chr 1BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
13 |
|
20.4 |
ml/min/kg |
2.16 |
7.8 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57815 |
526 |
FHH-Chr 1BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77 days-91 days |
18 |
|
162.3 |
g |
2.9 |
12.2 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58415 |
526 |
FHH-Chr 1BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
16 |
|
37.61 |
degrees C |
0.13 |
0.51 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16838 |
381 |
FHH-Chr 1BN/Mcwi |
FAPGG metabolism-surface area product |
FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
35.13 |
ml/min/kg |
4.71 |
14.89 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58303 |
526 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
-8.24 |
null |
0.06 |
0.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54623 |
522 |
FHH-Chr 1BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
female |
77 days-91 days |
10 |
|
0.03 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58515 |
526 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
16 |
|
20.38 |
% |
3.17 |
12.67 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56287 |
522 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
24.78 |
% |
5.89 |
17.66 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55147 |
522 |
FHH-Chr 1BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
0.27 |
null |
0.01 |
0.04 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59849 |
526 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
19.0 |
% |
4.19 |
12.58 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55059 |
522 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
16 |
|
7.06 |
% |
2.26 |
9.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55087 |
522 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82 days-99 days |
9 |
|
33.98 |
mmHg |
0.8 |
2.4 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16095 |
381 |
FHH-Chr 1BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
119.87 |
mmHg |
4.19 |
12.56 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
|
46765 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
40.56 |
mmHg |
4.9 |
14.71 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47727 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
64.16 |
% |
1.79 |
5.07 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46345 |
461 |
FHH-Chr 1BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
10 |
|
223.08 |
beats/min |
5.09 |
16.11 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45174 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
47.68 |
% |
2.98 |
9.41 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47092 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
54.91 |
% |
3.73 |
11.2 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46092 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
39.82 |
mmHg |
8.0 |
23.99 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45285 |
461 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82 days-99 days |
12 |
|
110.85 |
mmHg |
3.17 |
10.97 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20066 |
381 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
14 |
|
75.26 |
ml/min |
2.67 |
9.98 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20787 |
381 |
FHH-Chr 1BN/Mcwi |
serum total protein level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77 days-91 days |
15 |
|
5.69 |
g/dl |
0.07 |
0.28 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36977 |
401 |
FHH-Chr 1BN/Mcwi |
serum total cholesterol level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77 days-91 days |
9 |
|
65.33 |
mg/dl |
2.05 |
6.16 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37123 |
401 |
FHH-Chr 1BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
14 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
237.27 |
% |
10.25 |
38.34 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14224 |
381 |
FHH-Chr 1BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
18 |
|
127.52 |
breaths/min |
6.5 |
27.56 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14809 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
16 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
135.29 |
% |
4.94 |
19.75 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13706 |
381 |
FHH-Chr 1BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77 days-91 days |
18 |
|
143.89 |
mmol/l |
0.4 |
1.68 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36567 |
401 |
FHH-Chr 1BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
%change=VE during 2-3 min hypercapnia/control during standard conditions |
304.19 |
% |
14.31 |
55.41 |
stop flow air displacement plethysmography |
0 |
0 |
|
|
Moms and pups used in studies were fed Teklad |
19226 |
381 |
FHH-Chr 1BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
9 |
|
3.7 |
ng/ml/h |
0.8 |
2.4 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52924 |
482 |
FHH-Chr 1BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
10 |
|
5.18 |
mmHg |
0.24 |
0.77 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47223 |
461 |
FHH-Chr 1BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
|
0.5 |
ml |
0.02 |
0.08 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17385 |
381 |
FHH-Chr 1BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
14 |
|
0.49 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17396 |
381 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
7.06 |
ml/min/g |
0.69 |
2.19 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44733 |
461 |
FHH-Chr 1BN/Mcwi |
plasma creatinine level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77 days-91 days |
15 |
|
0.28 |
mg/dl |
0.01 |
0.06 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39591 |
401 |
FHH-Chr 1BN/Mcwi |
plasma anion gap |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77 days-91 days |
15 |
|
26.87 |
mmol/l |
0.75 |
2.9 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38276 |
401 |
FHH-Chr 1BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49 days-63 days |
9 |
|
4.81 |
% |
2.75 |
8.25 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49422 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
14 |
|
174.24 |
% |
4.73 |
17.71 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54452 |
381 |
FHH-Chr 1BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
10 |
|
1152.5 |
s |
25.98 |
82.15 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46563 |
461 |
FHH-Chr 1BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
14 |
|
17.9 |
pg |
0.08 |
0.3 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40275 |
401 |
FHH-Chr 1BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
10 |
|
241.58 |
beats/min |
8.76 |
27.71 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47608 |
461 |
FHH-Chr 1BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
19 |
|
98.89 |
% |
0.58 |
2.54 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56329 |
522 |
FHH-Chr 1BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77 days-91 days |
12 |
|
0.41 |
x 1000 cells/ul |
0.06 |
0.2 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40346 |
401 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
|
28.69 |
ml/min |
1.09 |
4.23 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16162 |
381 |
FHH-Chr 1BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77 days-91 days |
13 |
|
56.87 |
% |
0.59 |
2.14 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59272 |
526 |
FHH-Chr 1BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77 days-91 days |
9 |
|
55.3 |
% |
0.61 |
1.84 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59283 |
526 |
FHH-Chr 1BN/Mcwi |
serum alanine aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77 days-91 days |
8 |
|
59.75 |
U/l |
3.9 |
11.03 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40740 |
401 |
FHH-Chr 1BN/Mcwi |
percent change in left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
59.13 |
% |
8.47 |
26.78 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48771 |
461 |
FHH-Chr 1BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77 days-91 days |
14 |
|
0.58 |
x 1000 cells/ul |
0.07 |
0.25 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38973 |
401 |
FHH-Chr 1BN/Mcwi |
red blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
9 |
|
9.51 |
x 10E6 cells/ul |
0.1 |
0.31 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39263 |
401 |
FHH-Chr 1BN/Mcwi |
mean corpuscular hemoglobin |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
9 |
|
18.62 |
pg |
0.15 |
0.44 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42571 |
401 |
FHH-Chr 1BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77 days-91 days |
18 |
|
0.21 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57978 |
526 |
FHH-Chr 1BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
12 |
|
46.96 |
% |
0.65 |
2.27 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41354 |
401 |
FHH-Chr 1BN/Mcwi |
absolute change in partial pressure of blood oxygen |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82 days-99 days |
9 |
|
8.72 |
mmHg |
2.11 |
6.32 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16303 |
381 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood oxygen |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82 days-99 days |
8 |
|
103.58 |
mmHg |
3.73 |
10.55 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16403 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
|
189.59 |
% |
9.27 |
35.92 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54103 |
381 |
FHH-Chr 1BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
16 |
|
0.33 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13949 |
381 |
FHH-Chr 1BN/Mcwi |
blood pH |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82 days-99 days |
8 |
|
7.48 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17095 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in blood pH |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82 days-99 days |
9 |
|
0.05 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19812 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
18 |
|
106.74 |
% |
3.08 |
13.07 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54004 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in partial pressure of blood carbon dioxide |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82 days-99 days |
9 |
|
-4.38 |
mmHg |
0.92 |
2.76 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20100 |
381 |
FHH-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
16 |
|
99.39 |
breaths/min |
6.41 |
25.66 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18436 |
381 |
FHH-Chr 1BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77 days-91 days |
12 |
|
4.81 |
x 1000 cells/ul |
0.49 |
1.71 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36921 |
401 |
FHH-Chr 1BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82 days-99 days |
9 |
|
106.96 |
mmHg |
2.73 |
8.2 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18895 |
381 |
FHH-Chr 1BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
10 |
|
440.48 |
beats/min |
9.55 |
30.21 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52530 |
482 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
9 |
|
166.93 |
mmHg |
4.8 |
14.41 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52560 |
482 |
FHH-Chr 1BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
7 |
|
0.35 |
mg/dl |
0.03 |
0.08 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52272 |
482 |
FHH-Chr 1BN/Mcwi |
heart rate |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82 days-99 days |
7 |
|
410.56 |
beats/min |
14.13 |
37.38 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14744 |
381 |
FHH-Chr 1BN/Mcwi |
body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
14 |
|
37.14 |
degrees C |
0.21 |
0.79 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13585 |
381 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82 days-99 days |
15 |
|
121.71 |
mmHg |
4.05 |
15.7 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14358 |
381 |
FHH-Chr 1BN/Mcwi |
blood pH |
resting on treadmill (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82 days-99 days |
8 |
|
7.46 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Dyets |
20158 |
381 |
FHH-Chr 1BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82 days-99 days |
9 |
|
7.45 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20651 |
381 |
FHH-Chr 1BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82 days-99 days |
22 |
|
169.8 |
g |
2.5 |
11.9 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Dyets |
17843 |
381 |
FHH-Chr 1BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
18 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
128.7 |
% |
4.99 |
21.18 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18558 |
381 |
FHH-Chr 1BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77 days-91 days |
18 |
|
9.49 |
mg/dl |
0.09 |
0.38 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36836 |
401 |
FHH-Chr 1BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82 days-99 days |
15 |
|
425.56 |
beats/min |
14.49 |
56.12 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17531 |
381 |
FHH-Chr 1BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
18 |
|
129.74 |
breaths/min |
5.56 |
23.59 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18280 |
381 |
FHH-Chr 1BN/Mcwi |
heart contraction pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
10 |
|
43.4 |
mmHg |
3.35 |
10.61 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50012 |
461 |
FHH-Chr 1BN/Mcwi |
heart contraction pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
10 |
|
43.3 |
mmHg |
2.9 |
9.17 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50023 |
461 |
FHH-Chr 1BN/Mcwi |
time to peak heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
10 |
|
1125.69 |
s |
42.89 |
135.62 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50242 |
461 |
FHH-Chr 1BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77 days-91 days |
18 |
|
0.19 |
mg/dl |
0.01 |
0.05 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42723 |
401 |
FHH-Chr 1BN/Mcwi |
serum aspartate aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77 days-91 days |
8 |
|
80.38 |
U/l |
3.22 |
9.12 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42796 |
401 |
FHH-Chr 1BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77 days-91 days |
18 |
|
105.56 |
mmol/l |
0.49 |
2.09 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40083 |
401 |
FHH-Chr 1BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77 days-91 days |
18 |
|
1.11 |
g/kg |
0.02 |
0.11 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59531 |
526 |
FHH-Chr 1BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77 days-91 days |
18 |
|
1.64 |
g/dl |
0.05 |
0.21 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
41104 |
401 |
FHH-Chr 1BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77 days-91 days |
18 |
|
15.11 |
mg/dl |
0.9 |
3.83 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41829 |
401 |
FHH-Chr 1BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77 days-91 days |
18 |
|
73.17 |
mg/dl |
1.06 |
4.49 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38485 |
401 |
FHH-Chr 1BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
10 |
|
146.91 |
mmHg |
5.97 |
18.87 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48650 |
461 |
FHH-Chr 1BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
10 |
|
278.29 |
beats/min |
12.74 |
40.29 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47597 |
461 |
FHH-Chr 1BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
12 |
|
8.76 |
x 10E6 cells/ul |
0.12 |
0.43 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42021 |
401 |
FHH-Chr 1BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
8 |
|
116.03 |
mmHg |
4.99 |
14.12 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45530 |
461 |
FHH-Chr 1BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77 days-91 days |
14 |
|
46.29 |
% |
0.49 |
1.82 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57564 |
526 |
FHH-Chr 1BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
60.57 |
% |
5.93 |
15.68 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57267 |
522 |
FHH-Chr 1BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
32 |
|
235.3 |
g |
3.8 |
21.5 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55221 |
522 |
FHH-Chr 1BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
32 |
|
175.1 |
g |
1.7 |
9.4 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55245 |
522 |
FHH-Chr 1BN/Mcwi |
body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
18 |
|
37.47 |
degrees C |
0.16 |
0.67 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16587 |
381 |
FHH-Chr 1BN/Mcwi |
body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
15 |
|
37.46 |
degrees C |
0.09 |
0.36 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16598 |
381 |
FHH-Chr 1BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
0.03 |
10E-7mol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55759 |
522 |
FHH-Chr 1BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
1.47 |
E-7mole |
0.41 |
1.15 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55962 |
522 |
FHH-Chr 1BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
1.11 |
g/mg |
0.14 |
0.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55831 |
522 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
-8.32 |
null |
0.22 |
0.66 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54633 |
522 |
FHH-Chr 1BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
0.03 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54717 |
522 |
FHH-Chr 1BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
19 |
|
0.03 |
10E-7mol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56254 |
522 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
23.86 |
% |
4.82 |
18.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56297 |
522 |
FHH-Chr 1BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
41.57 |
% |
5.87 |
21.97 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54822 |
522 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
19.67 |
% |
5.56 |
16.68 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55156 |
522 |
FHH-Chr 1BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
11 |
|
0.84 |
E-7mole |
0.09 |
0.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56562 |
522 |
FHH-Chr 1BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
16 |
|
0.38 |
null |
0.03 |
0.13 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59824 |
526 |
FHH-Chr 1BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
9.5 |
ml/min/kg |
1.31 |
4.15 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58700 |
526 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
44.14 |
% |
5.69 |
21.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57160 |
522 |
FHH-Chr 1BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
10 |
|
152.1 |
mmHg |
6.15 |
19.44 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45755 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
55.37 |
% |
3.7 |
11.71 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46081 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
49.61 |
% |
2.83 |
8.95 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47103 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
95.53 |
% |
9.46 |
29.91 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48310 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
16 |
|
119.63 |
% |
8.05 |
32.18 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53780 |
381 |
FHH-Chr 1BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
9 |
|
0.74 |
g |
0.04 |
0.12 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49086 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
14 |
|
136.82 |
% |
6.12 |
22.9 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54246 |
381 |
FHH-Chr 1BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
18 |
|
0.35 |
ml |
0.02 |
0.08 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15248 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in heart rate |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82 days-99 days |
8 |
heart rate during walking-heart rate during rest |
91.08 |
beats/min |
15.45 |
43.71 |
vascular fluid filled catheter |
0 |
0 |
|
|
Moms and pups used in studies were fed Teklad |
13398 |
381 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82 days-99 days |
7 |
|
115.24 |
mmHg |
4.79 |
12.67 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13531 |
381 |
FHH-Chr 1BN/Mcwi |
absolute change in blood pH |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82 days-99 days |
8 |
|
-0.01 |
null |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14763 |
381 |
FHH-Chr 1BN/Mcwi |
serum total protein level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77 days-91 days |
9 |
|
5.46 |
g/dl |
0.09 |
0.26 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36988 |
401 |
FHH-Chr 1BN/Mcwi |
serum total cholesterol level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77 days-91 days |
14 |
|
72.64 |
mg/dl |
4.1 |
15.35 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37112 |
401 |
FHH-Chr 1BN/Mcwi |
serum calcium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77 days-91 days |
9 |
|
8.91 |
mg/dl |
0.11 |
0.32 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36650 |
401 |
FHH-Chr 1BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
12 |
|
32.2 |
g/dl |
0.11 |
0.39 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37380 |
401 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
7.05 |
ml/min/g |
0.94 |
2.97 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46216 |
461 |
FHH-Chr 1BN/Mcwi |
absolute change in partial pressure of blood oxygen |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82 days-99 days |
7 |
|
-52.91 |
mmHg |
4.32 |
11.43 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19512 |
381 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
7.15 |
ml/min/g |
0.93 |
2.79 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46227 |
461 |
FHH-Chr 1BN/Mcwi |
heart weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
10 |
|
6.47 |
g/kg |
0.24 |
0.76 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45659 |
461 |
FHH-Chr 1BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
10 |
|
53.5 |
mmHg |
6.47 |
20.46 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45296 |
461 |
FHH-Chr 1BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49 days-63 days |
9 |
|
155.8 |
g |
7.2 |
21.6 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47881 |
461 |
FHH-Chr 1BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77 days-91 days |
18 |
|
0.2 |
mg/dl |
0.01 |
0.05 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42698 |
401 |
FHH-Chr 1BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
12 |
|
0.41 |
null |
0.04 |
0.15 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58128 |
526 |
FHH-Chr 1BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77 days-91 days |
12 |
|
0.04 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41456 |
401 |
FHH-Chr 1BN/Mcwi |
blood eosinophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77 days-91 days |
13 |
|
0.03 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41662 |
401 |
FHH-Chr 1BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
16 |
|
30.16 |
ml/min |
1.72 |
6.86 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16716 |
381 |
FHH-Chr 1BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77 days-91 days |
12 |
|
6.38 |
x 1000 cells/ul |
0.64 |
2.22 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39937 |
401 |
FHH-Chr 1BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
8 |
|
924.55 |
s |
40.3 |
113.98 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50145 |
461 |
FHH-Chr 1BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
14 |
|
14.79 |
g/dl |
0.15 |
0.56 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40179 |
401 |
FHH-Chr 1BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77 days-91 days |
10 |
|
0.27 |
null |
0.01 |
0.05 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58759 |
526 |
FHH-Chr 1BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77 days-91 days |
14 |
|
0.31 |
x 1000 cells/ul |
0.05 |
0.17 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40371 |
401 |
FHH-Chr 1BN/Mcwi |
serum urea nitrogen level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77 days-91 days |
13 |
|
23.15 |
mg/dl |
0.86 |
3.11 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40843 |
401 |
FHH-Chr 1BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
99.78 |
% |
0.22 |
0.67 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56489 |
522 |
FHH-Chr 1BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77 days-91 days |
18 |
|
101.11 |
U/l |
5.73 |
24.32 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42469 |
401 |
FHH-Chr 1BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77 days-91 days |
18 |
|
0.23 |
null |
0.01 |
0.06 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57953 |
526 |
FHH-Chr 1BN/Mcwi |
serum potassium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77 days-91 days |
10 |
|
5.31 |
mmol/l |
0.11 |
0.35 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38081 |
401 |
FHH-Chr 1BN/Mcwi |
serum sodium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77 days-91 days |
15 |
|
146.2 |
mmol/l |
0.69 |
2.68 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39403 |
401 |